Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Versus Dexmedetomidine for Patients Receiving Drug-Induced Sleep Endoscopy
NCT07459322Not yet recruiting
- Sponsor
- Fu Jen Catholic University Hospital
- Start
- Aug 2026
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of remimazolam in obstructive sleep apnea syndrome (OSAS) (2 arms), sponsored by Fu Jen Catholic University Hospital. Primary endpoints: Apneic events, Bradycardia and 4 more. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
obstructive sleep apnea syndrome (OSAS)
Beyond the preview
Go deeper on NCT07459322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07459322.